Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Medical statistics Stories

2013-08-26 12:25:04

Frost & Sullivan Presents Mytrus with 2013 North American Product Leadership Award in Clinical Trials SAN FRANCISCO, Aug. 26, 2013 /PRNewswire/ -- inVentiv Health, offering best-in-class clinical, commercial and consulting services to the biopharmaceutical industry, announced today that partner company Mytrus Inc. won Frost & Sullivan's prestigious Product Leadership Award for pioneering electronic informed consent for clinical trials. Informed consent is one of the most important, but...

2013-08-05 12:27:38

Expanded Leadership Team Will Help Oversee Significant New Business Wins PRINCETON, N.J., Aug. 5, 2013 /PRNewswire/ -- inVentiv Health Clinical, a leading global supplier of drug development services, today announced the appointment of a President of Phase II-IV Development, Chief Medical Officer, and Chief Financial Officer to strengthen the leadership team overseeing significant business growth. The expansion of the Executive Leadership Team represents an important investment...

2013-07-22 08:28:28

Imprimis Engages Agility Clinical, Inc., to Manage the Initiation and Execution of its Phase III Clinical Trial and Engages Neil Singla, M.D. as Pain Trial Expert SAN DIEGO, July 22, 2013 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), which is focused on the commercialization of compounded drug formulations utilizing the FDA 505(b)(2) development pathway, today announced it has received IRB approval for its Phase III clinical trial protocol of its lead product...

2013-07-17 10:19:17

A new study published in the open access journal PLOS Biology suggests that the scientific literature could be compromised by substantial bias in the reporting of animal studies, and may be giving a misleading picture of the chances that potential treatments could work in humans. Testing a new therapeutic intervention (such as a drug or surgical procedure) on human subjects is expensive, risky and ethically complex, so the vast majority are first tested on animals. Unfortunately, cost and...

2013-07-17 10:17:59

Clinical trials of drug treatments for neurological diseases such as Alzheimer's and Parkinson's often fail because the animal studies that preceded them were poorly designed or biased in their interpretation, according to a new study from an international team of researchers. More stringent requirements are needed to assess the significance of animal studies before testing the treatments in human patients, the researchers say. The team - led by John Ioannidis, MD, DSc, a professor of...

2013-06-30 23:17:30

WCCT Global had recently completed a 300 subject phase I clinical trial. Costa Mesa, CA (PRWEB) June 30, 2013 WCCT Global, a contract research organization with Early Development operations headquartered in Southern California announced the completion of their largest phase I clinical trial since their founding in 2003. Although WCCT has always had a strong focus on conducting large phase I clinical research studies, this is the first study that has required more than 300 participants to...

2013-06-28 20:22:31

WAYNE, Pa., June 28, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/vnda) announces that a class action lawsuit has been filed in the United States District Court for the District of Columbia on behalf of purchasers of Vanda Pharmaceuticals, Inc. ("Vanda" or the "Company") (NASDAQ: VNDA) between December 18, 2012 and June 18, 2013, inclusive (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20121112/MM11729LOGO ) For more information regarding...

2013-06-25 12:07:19

Hospital performance on publicly reported conditions (acute myocardial infarction [heart attack], congestive heart failure, and pneumonia), may potentially be used as a signal of overall hospital mortality rates, according to a study by Marta L. McCrum, M.D., of Harvard School of Public Health, Boston, and colleagues. Using national Medicare data from 2,322 acute care hospitals, the authors examined whether mortality -rates for publicly reported medical conditions are correlated with...

2013-06-24 12:25:40

BOSTON, June 24, 2013 /PRNewswire/ -- Deloitte has named Brett J. Davis general manager of Deloitte Health Informatics (DHI), a newly launched business providing advanced analytics services and products to health care providers, researchers and medical manufacturers. Davis, who recently joined Deloitte Consulting LLP as a principal, will work to expand DHI's solutions and network of collaborators in helping health organizations unlock the power of data to reduce costs, improve...

2013-06-12 16:26:34

LAWRENCEVILLE, N.J., June 12, 2013 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today issued the following statement regarding a blog entry posted by Alpha Exposure, Contributor, on Seeking Alpha.com: "Statements made in Alpha Exposure's blog entry are misleading and require clarification. As is common in the biotechnology and pharmaceutical industry, Celsion has conducted a comprehensive post hoc analysis of the data from its Phase III HEAT Study of ThermoDox® in...